Skip to content

Innoviva, Inc. INVA Asset turnover

Asset turnover at other companies

Pfizer logo
PfizerPFE
0.3×0.0×
Merck & Co. logo
Merck & Co.MRK
0.5×0.0×
AbbVie logo
AbbVieABBV
0.5×+0.1×
Insmed logo
InsmedINSM
0.4×+0.2×
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
0.3×+0.1×
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
0.2×0.0×

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.4B+9.7%
P/E3.5×
P/S4.1×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Calculated from Innoviva, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s asset turnover?
Innoviva, Inc. (INVA) reported asset turnover of 0.3× in Q1 2026.
How has Innoviva, Inc.'s asset turnover changed year-over-year?
Innoviva, Inc.'s asset turnover decreased by 7.2% year-over-year, from 0.3× to 0.3×.
What is the long-term trend for Innoviva, Inc.'s asset turnover?
Over 5 years (2020 to 2025), Innoviva, Inc.'s asset turnover has grown at a -6.4% compound annual growth rate (CAGR), from 0.4× to 0.3×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.